Exelixis reported $0 in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0M 0.17M
Akebia Therapeutics AKBA:US $ 97.23M 0.31M
Amgen AMGN:US $ 33291M 4833M
AstraZeneca AZN:LN 28939M 4338M
Bayer BAYN:GR € 36974M 310M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Cytokinetics CYTK:US $ 124.09M 3.8M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eisai 4523:JP Y 49919M 6M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Esperion Therapeutics ESPR:US $ 272.51M 410K
Exelixis EXEL:US $ 0M 0M
Genmab GEN:DC 374M 10M
Glaxosmithkline GSK:US $ 20736M 294M
IONIS PHARMACEUT IONS:US $ 1303M 62.3M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 238M 90M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 330.7M 4.4M
Novartis NOVN:VX SF 24715M 1776M
Puma Biotechnology PBYI:US $ 96.8M 28.1M
Seattle Genetics SGEN:US $ 0M 0M
Takeda 4502:JP Y 4016473M 365116M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.38M 0.46M